Carregant...
Role of HGF–MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer
The Hepatocyte growth factor (HGF)—mesenchymal-epithelial transition (MET) pathway is deregulated in several cancers and is associated with aggressive phenotype and worse prognosis. MET, a tyrosine kinase receptor activated by HGF, plays a physiological role in embryogenesis, promoting cell growth,...
Guardat en:
| Publicat a: | Biomedicines |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5344276/ https://ncbi.nlm.nih.gov/pubmed/28548075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines2040345 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|